PubRank

M A Nalesnik

Author PubWeight™ 91.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984 5.74
2 Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet 1984 4.49
3 Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc 1987 4.21
4 Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol 1994 2.68
5 Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet 1986 2.07
6 Identification of bipotential progenitor cells in human liver development. Hepatology 1996 1.84
7 The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988 1.72
8 Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation 1999 1.70
9 Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 1980 1.64
10 Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol 2000 1.56
11 Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation 2000 1.53
12 Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol 1993 1.33
13 A fresh look at augmenter of liver regeneration in rats. Hepatology 1999 1.32
14 Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998 1.28
15 Identification of bipotential progenitor cells in human liver regeneration. Lab Invest 1996 1.26
16 Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J Immunol 1995 1.25
17 Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 1997 1.22
18 Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 1988 1.19
19 Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol 2001 1.18
20 An update on donor-derived disease transmission in organ transplantation. Am J Transplant 2011 1.15
21 Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol 1995 1.15
22 Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility. Gut 2003 1.12
23 Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 1997 1.08
24 FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats. Hepatology 1991 1.05
25 Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus. Mod Pathol 1995 1.02
26 Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patients. Clin Cancer Res 2001 1.01
27 Oxygen free radical content and neutrophil infiltration are important determinants in mucosal injury after rat small bowel transplantation. Transplantation 1996 0.99
28 Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injury. Am J Transplant 2006 0.99
29 Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol 1989 0.99
30 Causes of death in autopsied liver transplantation patients. Mod Pathol 1998 0.98
31 Characterization of ductular hepatocytes in primary liver allograft failure. Mod Pathol 1997 0.97
32 In situ hybridization of albumin mRNA in normal liver and liver tumors: identification of hepatocellular origin. Virchows Arch B Cell Pathol Incl Mol Pathol 1993 0.96
33 Infarcted regenerative nodules in cirrhosis: CT and MR imaging findings with pathologic correlation. AJR Am J Roentgenol 2000 0.96
34 Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection. Haemophilia 2009 0.96
35 Enhanced synthesis and reduced metabolism of endothelin-1 (ET-1) by hepatocytes--an important mechanism of increased endogenous levels of ET-1 in liver cirrhosis. J Hepatol 2000 0.96
36 Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation 2002 0.91
37 De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis. Liver Transpl Surg 1999 0.91
38 Ex vivo application of carbon monoxide in UW solution prevents transplant-induced renal ischemia/reperfusion injury in pigs. Am J Transplant 2010 0.91
39 Microchimerism, GVHD, and tolerance in solid organ transplantation. Transfusion 2001 0.91
40 Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol 2004 0.91
41 Allografts surviving for 26 to 29 years following living-related kidney transplantation: analysis by light microscopy, in situ hybridization for the Y chromosome, and anti-HLA antibodies. Am J Kidney Dis 1994 0.90
42 Genotypic analyses of cyclosporine-associated lymphoproliferations. Transplantation 1987 0.90
43 Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring? Am J Transplant 2011 0.88
44 Primary pleural effusion posttransplant lymphoproliferative disorder: Distinction from secondary involvement and effusion lymphoma. Diagn Cytopathol 2001 0.86
45 Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals. Transplantation 2000 0.86
46 Detection of infectious baboon cytomegalovirus after baboon-to-human liver xenotransplantation. J Virol 2001 0.86
47 Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients. Hum Pathol 1996 0.85
48 Sequential analyses of the development of lymphoproliferative disorders in rats receiving cyclosporine. Transplantation 1984 0.85
49 Spindle cell tumor of the portal vein. J Surg Oncol 1995 0.84
50 Alloimmune hepatitis following peripheral stem cell transplantation. Bone Marrow Transplant 2007 0.83
51 Communication gaps associated with donor-derived infections. Am J Transplant 2014 0.83
52 ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy. Autoimmunity 1993 0.83
53 Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis 1988 0.83
54 Concomitant and isolated expression of TGF-alpha and EGF-R in human hepatoma cells supports the hypothesis of autocrine, paracrine, and endocrine growth of human hepatoma. J Surg Oncol 1995 0.83
55 Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia. Haemophilia 2010 0.81
56 Hepatocyte growth factor mRNA in human liver cirrhosis as evidenced by in situ hybridization. Scand J Gastroenterol 1996 0.81
57 Effect of FK 506 on spontaneous diabetes in BB rats. Diabetes 1990 0.81
58 Herpesvirus 6 variant A infection after heart transplantation with giant cell transformation in bile ductular and gastroduodenal epithelium. Am J Surg Pathol 1997 0.81
59 Reversal of graft-versus-host disease with infusion of autologous bone marrow. Cell Transplant 1994 0.79
60 Combined effects of FK506 (tacrolimus) and cyclophosphamide on atypical B220+ T cells, cytokine gene expression and disease activity in MRL/MpJ-lpr/lpr mice. Clin Exp Immunol 1995 0.79
61 Primary lymphadenopathic Kaposi's sarcoma in an immunocompetent 23-year-old man. Am J Clin Pathol 1986 0.79
62 Cancers among US organ donors: a comparison of transplant and cancer registry diagnoses. Am J Transplant 2014 0.78
63 Clonal and morphological variation in a posttransplant lymphoproliferative disorder: evolution from clonal T-cell to clonal B-cell predominance. Hum Pathol 1998 0.78
64 The potential role of cytokines in the pathogenesis of Epstein-Barr virus associated post-transplant lymphoproliferative disease. Leuk Lymphoma 1994 0.78
65 Suppression of autoimmune thyroid disease by FK 506: influence on thyroid-infiltrating cells, adhesion molecule expression and anti-thyroglobulin antibody production. Clin Exp Immunol 1993 0.77
66 FK 506 inhibits cytokine gene and adhesion molecule expression in psoriatic skin lesions. Ann N Y Acad Sci 1993 0.77
67 Decreased mucosal IgA levels in ileum of patients with chronic ulcerative colitis. Dig Dis Sci 1995 0.77
68 Lymphoepithelial carcinoma of the larynx and hypopharynx: study of eight cases with relationship to Epstein-Barr virus and p53 gene alterations, and review of the literature. Hum Pathol 1996 0.76
69 Evidence that small bowel preservation causes primarily basement membrane and endothelial rather than epithelial cell injury. Transplantation 1993 0.76
70 Cross-species graft-versus-host-disease is accompanied by a donor-derived cellular immune response. Transplantation 1993 0.76
71 Pathologic analysis of recurrent posttransplant lymphoproliferative disorders. Transplant Proc 1995 0.75
72 Long-term function and morphology of intestinal allografts in outbred canine transplantation model. Transplant Proc 2002 0.75
73 The surgical implications of the posttransplant lymphoproliferative disorders. Transplant Proc 1991 0.75
74 Epstein-Barr virus-encoded RNA expression as a risk factor for the development of posttransplantation lymphoproliferative disease. Hepatology 1995 0.75
75 Effects of immunotherapy on experimental immunodeficiency-related lymphoproliferative disease. Transplantation 1998 0.75
76 FK 506 modulates D-galactosamine-induced hepatitis in rats. Transplant Proc 1991 0.75
77 Quantitative analysis of microchimerism with Y-chromosome-specific PCR in canine small bowel transplantation. Transplant Proc 2000 0.75
78 Immunodulation of intestinal transplantation: antilymphocyte serum donor pretreatment vs. ex vivo graft irradiation. Transplant Proc 2002 0.75
79 Small bowel preservation causes basement membrane and endothelial cell injury. Transplant Proc 1994 0.75
80 Posttransplant lymphoproliferative disease of donor origin. Arch Pathol Lab Med 1997 0.75
81 Cytologic features of post-transplant lymphoproliferative disorder. Diagn Cytopathol 1997 0.75
82 Subcutaneous implantation of human post-transplant lymphoproliferative disease lesions in SCID mice. Hematol Oncol 1997 0.75
83 Intrathymic transplantation of hepatocytes is facilitated by the addition of pancreatic islets. Transplant Proc 1992 0.75
84 Renal cortical neoplasms in long term survivors of solid organ transplantation. Transplantation 2000 0.75
85 Intracranial lipoma with hematopoietic elements (myelolipoma): report of a case with successful surgical resection. Cancer 1982 0.75
86 Cross species graft-versus-host disease induces hepatic injury in association with a donor-derived cellular immune response. Transplant Proc 1993 0.75
87 Occult nonhematopoietic malignancies present at autopsy in solid organ transplant patients who died within 100 days. Transplantation 2001 0.75
88 Extramedullary hematopoiesis in the allograft liver. Mod Pathol 1995 0.75
89 A combination study design to examine mycophenolate mofetil (MMF) and PTLD in renal transplant patients. Pharmacoepidemiol Drug Saf 1999 0.75
90 Quantitative assessment of the development of hepatoma in a buffalo rat model. Transplant Proc 1997 0.75
91 Expression of HGF mRNA in human rejecting kidney as evidenced by in situ hybridization. Urol Res 1996 0.75
92 Polymorphism and T-cell infiltration in posttransplant lymphoproliferative disorders. Transplant Proc 1999 0.75
93 Intestinal function and morphology after ex vivo irradiated small bowel transplantation. Transplant Proc 2002 0.75
94 EBER gene expression in Epstein-Barr virus-associated hematopoietic neoplasms. Leuk Lymphoma 1994 0.75
95 Oxygen free radical formation is related to mucosal injury during reperfusion after rat small bowel transplantation. Transplant Proc 1994 0.75
96 Xenogeneic graft-versus-host disease is associated with elevated levels of reactive nitrogen intermediates. Transplant Proc 1992 0.75
97 Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease. In Vitro Cell Dev Biol Anim 1994 0.75
98 A comparison of indirect immunofluorescence and the avidin-biotin-peroxidase conjugate technic (ABC) in the performance of the antinuclear antibody test. Am J Clin Pathol 1984 0.75